Myths and Beliefs In the Use of Folic Acid - Klaus Kraemer and Monika Potter Hidden Hunger - From Assessment to Solutions
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Myths and Beliefs In the Use of Folic Acid Klaus Kraemer and Monika Potter Sight and Life, Switzerland Hidden Hunger - From Assessment to Solutions
Overview of myths and beliefs Folic acid (FA) supplementation recommendations effectively reduce the risk of neural tube defects (NTDs) FA fortification… …masks vitamin B12 deficiency …leads to intakes above the tolerable upper intake level (UL) …increases the risk of cancer …changes the properties of drugs
FA supplementation recommendations effectively reduce the risk of NTDs Rates of NTDs per 10,000 births (1988 to 1998): Conclusion: NTDs/10 000 births NTDs/10 000 births NTDs/10 000 births “Recommendations on use of folic acid have had no detectable impact on incidence of neural tube defects, regardless of the recommendations’ form, timing, and intended target” “ In addition to actively promoting the use of supplements, public health agencies and medical professionals should strongly consider implementing food fortification programmes” indicates time of supplement intake recommendations in each country Blank top indicates terminated pregnancies Incidence rate ratio (IRR) estimates the average yearly change in rate Botto et al. BMJ. 2005; (1 indicates increasing rates) 330(7491):571 Botto et al. BMJ. 2005; 330(7491):571.
FA fortification masks vitamin B12 deficiency Folic Acid Metabolic Pathway: Methylated Product Substrate (e.g. DOPA, myelin basic protein, methylated lipids) (e.g. Lipids, proteins) S-Adenosylhomocysteine S-Adenosylmethionine Homocysteine Methionine Methionine synthase Vitamin B12 5-Methyl- Tetrahydrofolate tetrahydrofolate Anemia 5,10-Methylene- tetrahydrofolate reductase Purines 5,10-Methylene- 10-Formyl- Dihydrofolate tetrahydrofolate tetrahydrofolate Pyrimidines Folic acid Adapted from Kraemer and Zimmermann. Nutritional Anemia. Sight and Life. 2007 (p.113)
FA fortification masks vitamin B12 deficiency USA: Effect of FA Grain Fortification (median age: 67 years) Subjects with low NO EFFECT: vitamin percentage of people B12 but without Conclusion: with low vitamin B12 anemia but without anemia (%) before, during, and “There are no reports from countries after fortification: that have introduced mandatory fortification not significantly indicating deleterious effects on older people with different low vitamin B12 status.” - Scientific Advisory Committee on Nutrition 2006 Optional fortification: Mandatory fortification: March 1996 January 1998 Mills et al. Am J Clin Nutr. 2003;77(6):1474-7.
FA fortification leads to intakes above the UL Canada: Intakes above the UL Children and adolescents (1 – 19 years) UL (1-3 years): 300 µg FA/day UL (4-8 years): 400 µg FA/day UL UL (9-13 years): (14-18 years): 600 µg FA/day 800 µg FA/day Conclusion: In Canada only children and adults who dietary FA intake: consumed above the UL based on mandated fortification levels: 0% FA supplements had adjusted for overages in fortified foods: FA intakes above the 0% UL. adjusted for overages in fortified foods plus supplements: 1.2 to 4.0% In the USA children 1 to 8 years might exceed the UL based on folate intake from food alone which is probably due to Adults (>19 years) higher FA fortification levels in the USA. UL (>19 years): 1000 µg FA/day dietary FA intake: above the UL based on mandated fortification levels: 0% adjusted for overages in fortified foods: 0% Shakur et al. Am J Clin Nutr. adjusted for overages in fortified foods plus supplements: 1.2 to 5.0% 2010;92(4):818-25. Hennessy-Priest et al. Public Health Nutr. 2009;12(9):1548-55. Bailey et al. Am J Clin Nutr. 2010;92(2):353-8. Shakur et al. Am J Clin Nutr. 2010;92(4):818-25.
FA fortification increases the risk of cancer Incidence of Colorectal Cancer (CRC) USA Canada Fortification of flour and all cereal products 1996-1998 Fortification of flour 1998 Mason et al. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1325-9.
FA fortification increases the risk of cancer Herrmann and Obeid Dtsch Arztebl Int 2011; 108(15): 249–54.
FA fortification increases the risk of cancer Effects of FA supplementation (0.5 mg to 5 mg/day) on overall first cancer incidence: n=49 621 Conclusion: FA treatment: NO significant “allocation to folic acid (0.5mg–5mg/day) effect on overall for an average duration of 5 years cancer incidence had no significant effect on overall or site-specific cancer incidence during the scheduled treatment period.” “Nationwide dietary fortification involves doses of folic acid that are an order of magnitude lower than the doses studied in these trials.” Vollset et al. 2013. Lancet. Vollset et al. 2013. Lancet. RR=rate ratio; ICD=International Classification of Diseases
FA fortification… …changes the properties of drugs Reference:Dzinjalamala et al. Am J Trop Med Hyg. 2005;72(3):267-72.
FA fortification changes the properties of drugs Malaria: Gambia: Pregnant women received: 500–1,500 µg of FA per day + Sulfadoxine-pyrimethamine (SP) - folate antagonists “…in an area of low SP resistance, administration of folic acid to pregnant women in a dose of 500–1,500 µg/day will not interfere with the protective effect of SP when used for IPTp” (IPTp: intermittent preventive treatment) Mbaye et al. Am J Trop Med Hyg. 2006;74(6):960-4.
FA fortification changes the properties of drugs Malaria: WHO recommendations (2012) for areas of the Sahel sub-Region of Africa: “The (malaria prevention) strategy involves the administration of monthly courses of amodiaquine plus sulfadoxine- pyrimethamine to all children under 5 years of age during the high transmission season.” http://www.who.int/mediacentre/factsheets/fs094/en/ (accessed 7.2.2013)
FA fortification changes the properties of drugs Malaria: Pemba substudy (Children 1-35 months of age): Daily tablet [Iron (12.5 mg), FA (50 µg), with or without Zn (10 mg)] or Placebo (half a tablet if 100 8.00 7.44 1.08 (0.58-1.98) 0.8 Iron-replete and anaemic 8.33 4.17 2.00 (0.46-8.75) 0.36 Iron-replete and non-anaemic 7.63 5.06 1.51 (0.57-3.98) 0.41 Iron-deficient and anaemic 5.13 10.11 0.51 (0.31-0.83) 0.006 Iron-deficient and non-anaemic 8.29 9.09 0.91 (0.42-1.98) 0.82 *deaths, hospital admissions suggests: additional treatments at community level reduces hospital admissions and deaths Sazawal et al. Lancet. 2006; 367(9505):133-43.
FA fortification changes the properties of drugs Malaria: South Africa Number of under-five deaths from malaria 100 90 Initiation of FA 80 fortification 70 Number of under- Conclusion: 60 five deaths from 50 malaria 40 30 The role 20 and dose of FA in malaria endemic areas is not conclusive. 10 0 The management of malaria needs to improve. 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2008: 90% of wheat flour and 70% of maize flour on the market were fortified > 20 million people (66.5% of the population) consumed fortified wheat flour and maize meal http://gainmap.gainhealth.org/admin/pdf/Africa.pdf http://apps.who.int/ghodata/?vid=18400&theme=country#
Conclusions Recommendations on the use of FA supplements have no detectable impact on incidence of neural tube defects. There are no reports as yet from countries that have introduced mandatory fortification indicating an increase of elderly with a low vitamin B12 status but without anemia. Intakes above the UL are unlikely, even with supplementation, if appropriate mandated fortification levels are followed. FA supplementation has no significant effect on the overall cancer incidence. The role of FA drug interactions in malaria endemic areas are not conclusive.
Thank you!
You can also read